In vitro antitumor effect of adenovirus containing CD-TK fusion gene driven by VEGF promoter on LoVo cells

Abstract

Abstract: Objective To evaluate the in vitro antitumor effect of adenovirus containing cytosine deaminase (CD) and thymine kinase (TK) gene driven by vascular endothelial growth factor (VEGF) promoter (Ad-VEGFp-CDglyTK) on human colorectal cancer LoVo cells.Methods The adenoviral vectors Ad-VEGFp-CDglyTK, Ad-CMV-CD, Ad-CMV-TK and Ad-CMV- CDglyTK were transfected into LoVo cells, which were then treated with the prodrugs 5-FC or GCV to observe the plating efficiency and growth inhibition effect and bystander effect of the vectors on LoVo cells.Results Compared with the two vectors containing single suicide gene, Ad-VEGFp-CDglyTK showed more remarkable inhibitory effect on the plating efficiency and growth of the tumor cells, and the bystander effect of the fusion suicide gene was much stronger than that produced by single suicide gene. But the LoVo cells infected with Ad-VEGFp-CDglyTK exhibited similar sensitivity to the prodrugs with the cells infected with Ad-CMV-CDglyTK.Conclusion Ad-VEGFp-CDglyTK has potent antitumor effect on LoVo cells in vitro, which is comparable with the effect of Ad-CMV-CDglyTK.

CLC Number:

R730.59

HUANG Zong-hai, CHEN Jian-xiong, SU Guo-qiang. In vitro antitumor effect of adenovirus containing CD-TK fusion gene driven by VEGF promoter on LoVo cells[J]. Journal of Southern Medical University, 2005, 25(05): 521-523.

References

[1] 黄元媛,黄宗海,陈建发,等.新法制备含VEGF启动子驱动的CD/TK融合基因重组腺病毒[J] 第一军医大学学报,2004,24(1):117-20.Huang YY, Huang ZH, Chen JF, et al. An easier method for generating recombinant adenovirus containing CD/TK fusion gene driven by the vascular endothelial growth factor promoter [J]. J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao, 2004, 24(1): 117-20.
[2] 陈建发,黄宗海,俞金龙,等.含血管内皮生长因子启动子驱动TK自杀基因重组腺病毒的制备及其体外杀伤作用观察[J].第一军医大学学报,2004,24(6):623-7.Chen JF, Huang ZH, Yu JL, et al. Construction of recombinant adenoviruses containing cytosine deaminase gene driven by the vascular endothelial growth factor promoter using an AdEsier-1 system [J]. J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao,2004, 24(6): 623-7.
[3] Suhardja A, Hoffman H. Role of growth factors and their receptors in proliferation ofmicrovascular endothelial cells[J]. Microsc Res Tech,2003, 60: 70-5.
[4] Underiner TL, Ruggeri B, Gingrich DE. Development of vascular endothelial growth factor receptor (VEGFR) kinase inhibitors as anti-angiogenic agents in cancer therapy[J]. Curr Med Chem, 2004,11: 731-45.
[5] Qi L, Robinson WA, Brady BM, et al. Migration and invasion of human prostate cancer cells is related to expression of VEGF and its receptors[J]. Anticancer Res, 2003, 23: 3917-22.
[6] 黄宗海,陈治,钱伟峰,等.血管内皮细胞生长因子及其受体在大肠癌组织中的表达[J].第一军医大学学报,2001,21(3):206-8.Huang ZH, Chen Z, Qian WF, et al. Expression of vascular endothelial growth factor and its receptor in colorectal carcinoma [J]. J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao, 2001, 21(3): 206-8.
[7] Nicholas TW, Read SB, Burrows FJ, et al. Suicide gene therapy with herpes simplex virus thymidine kinase and ganciclovir is enhanced with connexins to improve gap junctions and bystander effects [J].Histol Histopathol, 2003, 18(2): 495-507.
[8] Denny WA. Tumor-activated prodrugs-a ew approach to cancer therapy[J]. Cancer Invest, 2004, 22(4): 604-19.